The new company will benefit from the extensive manufacturing and product development experience of its owners to bring to market their ranges of extensively used medicated feed additives and innovative new therapeutic compounds for livestock and poultry. Its low-cost structure will optimize the supply chain for a range of the most broadly utilized drugs and will be backed by a specialist sales and technical team.
Colin Gray, general manager of Pharmgate, part of Jinhe Biotechnology Ltd of China, commented, “We are excited to take this important step in the forward integration of Pharmgate into the North American market. Our FDA-approved manufacturing facilities in China meet the highest international quality, safety and environmental standards and are well-known to the industry. We look forward to satisfying our customers’ requirements for a streamlined, no-nonsense source of key animal health products.”
Marc Loomes, chief executive of ECO Animal Health Group plc (AIM: EAH), the parent of ECO Animal Health Ltd, said, “This is an important step in the global commercialization of Aivlosin®, our novel antibiotic for the treatment of enteric and respiratory disease in swine and poultry. Pre-approval studies in the US market have shown similar performance of Aivlosin® to that seen in markets where the product is already being successfully sold, including Europe, Central and Latin America, China, Japan, South East Asia and Africa. After evaluating many options we have selected Pharmgate as our partner in North America. Pharmgate shares ECO’s marketing philosophy and pursuit of lean and agile field operations.”
About Pharmgate LLC
Pharmgate LLC is the majority-owned US subsidiary of Jinhe Biotechnology Co., Ltd., P. R. China, the world leader in the production of chlortetracycline feed grade, chlortetracycline hydrochloride, salinomycin and other animal health compounds. The company has marketing or supply approvals for these products in most major markets throughout the world.
Contact: Colin Gray +1 201 327 3800
About ECO Animal Health Ltd
ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel macrolide antibiotic, Aivlosin®, as well as a range of generic therapeutic products.
ECO Animal Health Group plc
Marc Loomes +44 (0) 20 8447 8899
Anthony Spiro +44 (0) 20 8336 6196
Cenkos Securities plc
Stephen Keys +44 (0) 20 7397 8926